Columbia Care to Open 20 Dispensaries in Florida

Columbia Care预计2019年底前在佛罗里达州增加开设20家医用大麻药房

2019-07-12 08:00:00 Investing News Network

本文共1407个字,阅读需4分钟

Columbia Care announced the opening of 20 medical cannabis dispensaries in Florida last Thursday . The company expects to have all 20 dispensaries either open or under development in the state by the end of 2019. The first of the company’s new dispensaries in Florida will be its 4,000 square foot Gainesville location set to open on July 16. Columbia Care CEO Nicholas Vita said in a press release that the rapid growth of cannabis providers and patients in Florida makes the state a prime location. “Since acquiring our Florida license in 2018, Columbia Care has been quietly assembling its portfolio of dispensaries and building the requisite infrastructure to support the pace of growth that has made the State such a strategic market,” said Vita. The Gainesville facility will offer Columbia Care’s tinctures, capsules and vaporization devices for medical use. The company also intends to make its in-house medical cannabis brands available in tablet and topical form by the end of the year. Analyst Matt Bottomley, director of equity research at Canaccord Genuity, has spoken highly of Florida as one of the growing cannabis markets in the US. Haywood Securities analyst Neal Gilmer shares that sentiment. In a 2018 report on the cannabis market in the US, Gilmer wrote that, while Florida is in the early stages of cannabis adoption, “we believe (it) will continue to support strong growth metrics as the medical program continues to evolve.” Cannabis legalization has faced obstacles in the state. Despite a majority of Floridians — over 70 percent — voting for a constitutional amendment that would allow the use of cannabis for medical conditions in 2016, then-Governor Rick Scott signed a ban on smoking medical cannabis that was enacted in 2017. Earlier this year, Florida’s current governor, Ron DeSantis, signed legislation to overturn the ban. While recreational use is still illegal in the state, the recent legalization of smoking medical cannabis in Florida has made it an attractive market for multi-state operators (MSOs) like Columbia Care. Other MSOs in Florida have also taken note of the state’s quickly growing medical cannabis market. Cresco Labs (CSE:CL,OTCQX:CRLBF), a US cannabis company, made its entrance into Florida’s market with its agreement to acquire the ownership interests or assets of VidaCann, one of Florida’s largest providers of medical cannabis, earlier this year. Cresco Labs opened up its 12th VidaCann-branded medical marijuana dispensary in Florida last month. In its 2018 year-end financial report, released earlier this year, Curaleaf Holdings (CSE:CURA,OTCQX:CURLF) credited a boost in its revenue to its expansions in Florida and New York, as well as acquisitions in Arizona and Massachusetts. Another MSO, Trulieve Cannabis (CSE:TRUL,OTC Pink:TCNNF), saw a jump in its share price in March when it began to sell smokable medical cannabis products in Florida, becoming the first company in the state to sell “whole-flower smokable cannabis,” according to a press release. In a recent update from the Florida Office of Medical Marijuana Use, it was reported that there are currently 142 dispensary locations across Florida. Trulieve has the largest number of dispensaries with 30 locations, while Curaleaf and VidCann have 25 and 12 locations, respectively. According to Statista, medical cannabis sales in Florida will be valued at about US$2.5 billion by 2025. Shares of Columbia Care opened at C$5.87 Wednesday (July 10) and closed at C$5.61. Since its announcement on July 5, the company’s share price has dipped 16 percent from C$6.69.
哥伦比亚医疗公司( ColumbiaCare )上周四宣布在弗洛里达州开设20家医用大麻药房。 该公司预计,到2019年底,该州将有全部20家药房开业或正在开发之中。 该公司在弗洛里达州的第一家新药房将于7月16日开业,占地4,000平方英尺的盖恩斯维尔( Gainesville )门店将开业。哥伦比亚医疗公司首席执行官 NicholasVita 在一份新闻稿中说,弗洛里达州大麻提供者和患者的快速增长使该州成为主要的所在地。 Vita 表示:“自2018年获得我们在弗洛里达州的许可以来,哥伦比亚医疗一直在悄悄地组装其药房组合,并建立必要的基础设施,以支持增长速度,这使得美国成为了一个如此战略的市场。” 盖恩斯维尔设施将提供哥伦比亚医疗公司的酊剂、胶囊和汽化设备供医疗使用。公司还拟在年底前将公司内部的医用大麻品牌以片剂和外用形式上市。 Canaccord Genuity 股权研究主管马特•波托姆利( Matt Bottomcley )曾高度评价弗洛里达州是美国大麻市场日益增长的地区之一。 Haywood 证券分析师 NealGilmer 对此持股.吉尔默在2018年关于美国大麻市场的报告中写道,尽管弗洛里达州正处于大麻收养的早期阶段,“我们相信(它)将继续支持强有力的增长指标,因为医疗计划不断发展。” 大麻合法化在国家面临障碍。尽管大多数佛罗里达人(超过70%)投票赞成宪法修正案,允许在2016年将大麻用于医疗状况,但时任州长 Rick Scott 签署了一项禁止吸烟的医用大麻的禁令,该禁令于2017年颁布。 今年早些时候,弗洛里达州现任州长罗恩•德桑蒂斯( Ron DeSantis )签署了推翻这项禁令的立法。 虽然娱乐用途在该州仍然是非法的,但最近弗洛里达州的大麻吸食合法化使得它成为多州运营商(如哥伦比亚医疗)的一个有吸引力的市场。 弗洛里达州的其他 MSO 也注意到该州迅速增长的医用大麻市场。 美国大麻公司 Cresco Labs ( CSE : CL , OTCQX : CRLBF )今年早些时候同意收购佛罗里达州最大医用大麻供应商之一 VidaCann 的所有权权益或资产,从而进入弗洛里达州市场。上个月, Cresco 实验室在弗洛里达州开设了12家 VidaCann 品牌的医用大麻药房。 在今年早些时候发布的2018年年终财务报告中, Curaleaf Holdings ( CSE : CURA , OTCQX : CURLF )将收入增长归功于其在弗洛里达州和纽约的扩张,以及在亚利桑那州和马萨诸塞州的收购。 另一家名为 Trulieve Cannabis ( CSE : TRUL ,非处方药(OTC) Pink : TCNNIF )的 MSO 在今年3月开始在弗洛里达州销售易燃医用大麻产品,成为该州第一家销售“全花易燃大麻”的公司。 在佛罗里达医用大麻使用办公室最近的一次更新中,据报道,目前弗洛里达州有142家药房。Trulieve 的药房数量最多,有30家,而 Curaleaf 和 VidCann 分别有25家和12家。 根据 Statista 的数据,到2025年,弗洛里达州的医用大麻销售额将达到25亿美元左右。 哥伦比亚医疗的股票周三(7月10日)开盘报5.87加元,收盘报5.61加元。自7月5日宣布以来,该公司股价已从6.69加元下跌了16%。

以上中文文本为机器翻译,存在不同程度偏差和错误,请理解并参考英文原文阅读。

阅读原文